Cnpair Cardiac Markers Solutions for Advanced IVD Diagnostics
As the leading global threat to human health, cardiovascular diseases (CVDs) continue to rise in both incidence and mortality. According to the World Health Organization (WHO), approximately 17.9 million people die from cardiovascular diseases each year, accounting for nearly one-third of all global deaths. Meanwhile, data from the World Heart
Cnpair Blocking Agents: Reducing False Results from Antibody Interference
In in vitro diagnostic immunoassays, researchers often encounter persistent challenges such as elevated background signals, erratic test results, and discrepancies between detected values and actual sample conditions. Despite repeated troubleshooting, the root cause often remains elusive—suggesting the presence of interfering substances that can skew measurements. This represents a common pain
Cnpair Fertility Antibody & Antigen -supporting Every Journey to Healthy Motherhood
Motherhood begins with hope, love, and the courage to embrace a brand-new journey. This Mother’s Day, Cnpair celebrates every mom-to-be and every family preparing to welcome new life. We believe that behind every healthy pregnancy is not only care and support, but also trustworthy diagnostic technology that brings greater confidence
Cnpair Advances Early Raw Materials for Gastrointestinal Diseases
Spring brings warmer days — but also a seasonal rise in gastrointestinal infections.Pathogens associated with gastrointestinal diseases have become a major public health concern, especially for children and vulnerable populations worldwide. At Cnpair, we provide a range of high-quality core raw materials for gastrointestinal disease diagnostics, supporting projects including: Rotavirus
Native Antigen – Ideal Choice for Reagent Development
During your reagent development process, have you faced any of the following challenges? ·High development difficulty?·Poor stability?·High batch-to-batch variation?·Difficult to scale up for mass production? If so, we may have the solution you’ve been looking for. Cnpair high-activity raw materials —— native antigens are suitable for the development and production
Rising Influenza B in Spring: Ensuring Accurate Detection with Cnpair
Spring Arrives, but Influenza B Is Rising As we welcome the arrival of spring and the comfort of warmer days, many may expect the flu season to gradually subside. However, the reality tells a different story. While Influenza A infections are showing a declining trend, Influenza B is now on
Cnpair Syphilis Raw Material Upgrade – Powering Earlier and Accurate Diagnostics
According to the Japan Institute for Health Crisis Management (JIHS), Japan reported 13,294 new syphilis cases in 2025, marking the fourth consecutive year of sustained high incidence — a more than tenfold increase compared to approximately 1,000 cases in 2013. The WHO reported in 2024 that syphilis remains a major
Cnpair Empowering Early Syphilis Detection in Response to Japan’s Rising Case
According to reports, Japan has seen a sustained high level of syphilis infections in recent years, with confirmed cases exceeding 13,000 annually for four consecutive years. Health authorities have called for enhanced prevention, making early syphilis detection crucial. 🧪 hashtag#Cnpair provides multiple antigen and reagent combinations, including chimeric and single-fragment
Rapidly Escalating H3N2 Outbreak. Are Your Respiratory Tests Ready?
What is H3N2🦠? Why Should We Be More Vigilant This Year? H3N2 is a subtype of Influenza A virus that has circulated as a seasonal strain since it first triggered a global pandemic in 1968. According to the data from the European Centre for Disease Prevention and Control (ECDC), H3N2 has now surpassed
Flu season is coming
Flu season is coming —Recent international reports show an eraly rise in influenza activity this autumn — from the UK to Japan — reminding us that flu season is arriving sooner than expected. Cnpair enables highly efficient detection of the current H3N2 strain, ensuring accurate results even in low viral